Glioblastoma, IDH-wildtype Clinical Trials

36 clinical trials for Glioblastoma, IDH-wildtype across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial — RECRUITING · PHASE2
• Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma — RECRUITING · NA
• WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma — RECRUITING · PHASE2
• ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial — RECRUITING · PHASE1
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis — RECRUITING · PHASE1
• Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas — RECRUITING · PHASE1
• A Study of 177Lu-PSMA-617 in People With Gliomas — RECRUITING · PHASE1
• Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM — RECRUITING · PHASE3
• Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma — RECRUITING · PHASE3
• GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma — RECRUITING · PHASE2
• Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide — RECRUITING · PHASE2
• Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma — RECRUITING · PHASE2
• Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma — RECRUITING · PHASE1
• Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma — RECRUITING · NA
• Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma — RECRUITING · PHASE1
• Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma — RECRUITING · PHASE2
• The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) — RECRUITING
• The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma — RECRUITING
• The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) — RECRUITING
• Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis — RECRUITING
• The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203) — RECRUITING
• The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202) — RECRUITING
• THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM) — RECRUITING
• WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases — ACTIVE_NOT_RECRUITING · PHASE1
• A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden — ACTIVE_NOT_RECRUITING · PHASE2
• Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma — NOT_YET_RECRUITING · PHASE2
• Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas — NOT_YET_RECRUITING · PHASE2
• Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma — NOT_YET_RECRUITING · PHASE3
• Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma — ACTIVE_NOT_RECRUITING · PHASE1
• Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma — ACTIVE_NOT_RECRUITING · PHASE1
• Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients — COMPLETED · PHASE1
• Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter — TERMINATED · PHASE2
• BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels — COMPLETED
• Biomolecular Analysis for Predicting Response to Regorafenib — COMPLETED · NA
• SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors — COMPLETED · PHASE1
• Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma — NOT_YET_RECRUITING · PHASE2

Refine this search